Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

IVAX and Glaxo Wellcome to expand Easi-Breathe agreement

Nov. 21, 1996

LTB4-PPARalpha as a new target for drug design

Nov. 20, 1996

U.S. patents and suits related to transgenic mice producing human antibodies

Nov. 15, 1996

Patent covers Advanced Magnetics' targeted drug delivery system

Nov. 15, 1996

Alanex and Aurora join forces to identify new lead compounds

Nov. 15, 1996

CombiChem/Roche Bioscience drug discovery collaboration

Nov. 15, 1996

NIU researchers offer improved vector delivery system for ribozymes

Nov. 8, 1996

Scherer-Merck softgel development agreement

Nov. 8, 1996

CellPro to begin clinical trial of T-cell depletion system

Nov. 1, 1996

Lynx signs two agreements with BASF

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...